STAT+: Pharmalittle: Biogen CEO exits amid Aduhelm failures; FDA eschews its own outside expert panels
Rise and shine, everyone, another very busy day awaits. Even so, there is nothing like…
Category: Pharmalitte
Rise and shine, everyone, another very busy day awaits. Even so, there is nothing like…